Get notified when PMI files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Going Concern (new) — The auditor's report includes an explanatory paragraph raising substantial doubt about the company's ability to continue as a going concern.
- Material Weakness (new) — The company has concluded that its internal control over financial reporting was not effective as of December 31, 2025, due to material weaknesses.
- Controlled Company (new) — Hunniwell Picard I, LLC controls a majority of the voting power, and the company qualifies as a controlled company, allowing exemptions from certain governance requirements.
- Customer Concentration (new) — Customer A accounted for 43% of revenue in 2025, indicating significant reliance on a single customer.
- Product Concentration (new) — Substantially all revenue is expected to be derived from the SynCardia TAH, a single product with expired core patents.
- Dilution (new) — New investors face immediate dilution of $0.33 per share, and the offering includes warrants for up to 42.2M additional shares at the same price.
Picard Medical files for best-efforts offering of 21.1M shares plus warrants at $0.47, targeting $9.1M net proceeds
Filed May 1, 2026 · ~2 min read
Key Changes
-
high
Picard Medical is offering 21,114,865 shares at $0.47 per share on a best-efforts basis, with no minimum, so actual proceeds may be far less than the $9.1M net estimate.
The Offering verify on EDGAR → -
high
The company reported a GAAP net loss of $27.0M for 2025, up from $21.1M in 2024, and its auditor has raised substantial doubt about its ability to continue as a going concern.
Management's Discussion and Analysis verify on EDGAR → -
high
New investors face immediate dilution of $0.33 per share, as pro forma as adjusted net tangible book value is $0.14 versus the $0.47 assumed offering price.
Dilution verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (MU 10-K) is open in full — no account needed.
Partner
Trade PMI commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Aug 31, 2026 · How we verify